BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11217922)

  • 1. Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes.
    Karavellas MP; Azen SP; MacDonald JC; Shufelt CL; Lowder CY; Plummer DJ; Glasgow B; Torriani FJ; Freeman WR
    Retina; 2001; 21(1):1-9. PubMed ID: 11217922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
    Arevalo JF; Mendoza AJ; Ferretti Y
    Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anti-cytomegalovirus therapy on the incidence of immune recovery uveitis in AIDS patients with healed cytomegalovirus retinitis.
    Song MK; Azen SP; Buley A; Torriani F; Cheng L; Chaidhawangul S; Ozerdem U; Scholz B; Freeman WR
    Am J Ophthalmol; 2003 Oct; 136(4):696-702. PubMed ID: 14516810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy.
    Karavellas MP; Plummer DJ; Macdonald JC; Torriani FJ; Shufelt CL; Azen SP; Freeman WR
    J Infect Dis; 1999 Mar; 179(3):697-700. PubMed ID: 9952380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
    Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
    Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-recovery uveitis in patients with cytomegalovirus retinitis taking highly active antiretroviral therapy.
    Robinson MR; Reed G; Csaky KG; Polis MA; Whitcup SM
    Am J Ophthalmol; 2000 Jul; 130(1):49-56. PubMed ID: 11004259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune recovery vitritis].
    Dujić M; Jevtović D
    Srp Arh Celok Lek; 2007; 135(9-10):513-5. PubMed ID: 18088034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF; Garcia RA; Mendoza AJ
    Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome.
    Karavellas MP; Lowder CY; Macdonald C; Avila CP; Freeman WR
    Arch Ophthalmol; 1998 Feb; 116(2):169-75. PubMed ID: 9488268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.
    Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
    Ophthalmology; 2007 Apr; 114(4):787-93. PubMed ID: 17210182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis.
    Schrier RD; Song MK; Smith IL; Karavellas MP; Bartsch DU; Torriani FJ; Garcia CR; Freeman WR
    Retina; 2006 Feb; 26(2):165-9. PubMed ID: 16467672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Whitcup SM
    JAMA; 2000 Feb; 283(5):653-7. PubMed ID: 10665706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of treatment of macular complications in eyes with immune recovery uveitis using a graded treatment approach.
    El-Bradey MH; Cheng L; Song MK; Torriani FJ; Freeman WR
    Retina; 2004 Jun; 24(3):376-82. PubMed ID: 15187659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide for the treatment of immune recovery uveitis macular edema.
    Morrison VL; Kozak I; LaBree LD; Azen SP; Kayicioglu OO; Freeman WR
    Ophthalmology; 2007 Feb; 114(2):334-9. PubMed ID: 17270681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.
    Cassoux N; Lumbroso L; Bodaghi B; Zazoun L; Katlama C; LeHoang P
    Br J Ophthalmol; 1999 Jan; 83(1):47-9. PubMed ID: 10209434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of immune recovery vitritis with local steroids.
    Henderson HW; Mitchell SM
    Br J Ophthalmol; 1999 May; 83(5):540-5. PubMed ID: 10216051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric analysis of macular edema by scanning laser tomography in immune recovery uveitis.
    Bartsch DU; Aurora A; Rodanant N; Cheng L; Freeman WR
    Arch Ophthalmol; 2003 Sep; 121(9):1246-51. PubMed ID: 12963607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.
    Nguyen QD; Kempen JH; Bolton SG; Dunn JP; Jabs DA
    Am J Ophthalmol; 2000 May; 129(5):634-9. PubMed ID: 10844056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy.
    Goldberg DE; Wang H; Azen SP; Freeman WR
    Br J Ophthalmol; 2003 Jul; 87(7):853-5. PubMed ID: 12812884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.